Publications

List
Filtro

Filtros: First Letter Of Title es G [Restablecer todos los filtros]

A B C D E F [G] H I J K L M N O P Q R S T U V W X Y Z [Show ALL]

G

Sanz-Pamplona R, Cordero D, Berenguer A, Lejbkowicz F, Rennert H, Salazar R, et al. Gene expression differences between colon and rectum tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011;17(23):7303-12. Abstract

Fernández-Ramires R, Solé X, De Cecco L, Llort G, Cazorla A, Bonifaci N, et al. Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis. British journal of cancer. 2009;101(8):1469-80.

Salazar R, Roepman P, Capella G, Moreno V, Simon I, Dreezen C, et al. Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011;29(1):17-24. Abstract

Medina I, Montaner D, Bonifaci N, Pujana MA, Carbonell J, Tarraga J, et al. Gene set-based analysis of polymorphisms: finding pathways or biological processes associated to traits in genome-wide association studies. Nucleic acids research. 2009;37(Web Server issue):W340-4.

Solé X, Hernández P, de Heredia ML, Armengol L, Rodríguez-Santiago B, Gómez L, et al. Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility. BMC genomics. 2008;9:12.

Maxwell CA, Moreno V, Solé X, Gómez L, Hernández P, Urruticoechea A, et al. Genetic interactions: the missing links for a better understanding of cancer susceptibility, progression and treatment. Molecular cancer. 2008;7:4.

Crous-Bou M, Rennert G, Salazar R, Rodriguez-Moranta F, Rennert HS, Lejbkowicz F, et al. Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer. Mutagenesis. 2012;27(2):169-76. Abstract

Bellido F, Guinó E, Jagmohan-Changur S, Seguí N, Pineda M, Navarro M, et al. Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome. European journal of human genetics : EJHG. 2012. Abstract

Enjuanes A, Benavente Y, Bosch F, Martín-Guerrero I, Colomer D, Pérez-Alvarez S, et al. Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia. Cancer research. 2008;68(24):10178-86.

Lipkin SM, Chao EC, Moreno V, Rozek LS, Rennert H, Pinchev M, et al. Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer. Cancer prevention research (Philadelphia, Pa.). 2010;3(5):597-603. Abstract

Gruber SB, Moreno V, Rozek LS, Rennerts HS, Lejbkowicz F, Bonner JD, et al. Genetic variation in 8q24 associated with risk of colorectal cancer. Cancer biology & therapy. 2007;6(7):1143-7.

Martino A, Sainz J, Buda G, Jamroziak K, Reis RM, García-Sanz R, et al. Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). International journal of oncology. 2012;40(3):625-38. Abstract

Tenesa A, Farrington SM, Prendergast JG, Porteous ME, Walker M, Haq N, et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nature genetics. 2008;40(5):631-7.

Vendrell E, Ribas M, Valls J, Solé X, Grau M, Moreno V, et al. Genomic and transcriptomic prognostic factors in R0 Dukes B and C colorectal cancer patients. International journal of oncology. 2007;30(5):1099-107.

Marcuello E, Páez D, Paré L, Salazar J, Sebio A, del Rio E, et al. A genotype-directed phase I-IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer. British journal of cancer. 2011;105(1):53-7. Abstract